Ilaria Basile

Montpellier, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Therapeutic antibody engineering for efficient targeted degradation of membrane proteins in lysosomes.

Therapeutic antibody engineering for efficient targeted degradation of membrane proteins in lysosomes.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 10, 2024

Cation-independent mannose 6-phosphate receptor: From roles and functions to targeted therapies.

Cation-independent mannose 6-phosphate receptor: From roles and functions to targeted therapies.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: August 26, 2023

Engineered therapeutic antibodies with mannose 6-phosphate analogues as a tool to degrade extracellular proteins.

Engineered therapeutic antibodies with mannose 6-phosphate analogues as a tool to degrade extracellular proteins.

Journal: Frontiers in immunology

Published: August 05, 2023

Mannose 6-phosphate receptor-targeting antibodies preserve Fc receptor-mediated recycling.

Mannose 6-phosphate receptor-targeting antibodies preserve Fc receptor-mediated recycling.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 18, 2023

Vegetable oil-based hybrid microparticles as a green and biocompatible system for subcutaneous drug delivery.

Vegetable oil-based hybrid microparticles as a green and biocompatible system for subcutaneous drug delivery.

Journal: International journal of pharmaceutics

Published: July 28, 2020

Efficient Photodynamic Therapy of Prostate Cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor.

Efficient Photodynamic Therapy of Prostate Cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor.

Journal: International journal of molecular sciences

Published: May 15, 2019

Mannose 6-phosphonate labelling: A key for processing the therapeutic enzyme in Pompe disease.

Mannose 6-phosphonate labelling: A key for processing the therapeutic enzyme in Pompe disease.

Journal: Journal of cellular and molecular medicine

Published: March 29, 2019

Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid α-glucosidase.

Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid α-glucosidase.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: August 04, 2017

Design of Potent Mannose 6-Phosphate Analogues for the Functionalization of Lysosomal Enzymes To Improve the Treatment of Pompe Disease.

Design of Potent Mannose 6-Phosphate Analogues for the Functionalization of Lysosomal Enzymes To Improve the Treatment of Pompe Disease.

Journal: Angewandte Chemie (International ed. in English)

Published: August 11, 2016

Why Anticancer Nanomedicine Needs Sugars?

Why Anticancer Nanomedicine Needs Sugars?

Journal: Current medicinal chemistry

Published: July 23, 2015

Investigation of cyano-bridged coordination nanoparticles Gd(3+)/[Fe(CN)6](3-)/D-mannitol as T1-weighted MRI contrast agents.

Investigation of cyano-bridged coordination nanoparticles Gd(3+)/[Fe(CN)6](3-)/D-mannitol as T1-weighted MRI contrast agents.

Journal: Nanoscale

Published: May 14, 2015

Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer.

Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer.

Journal: Oncology reports

Published: April 16, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026